blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1953551

EP1953551 - Prion protein ligands and methods of use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.12.2014
Database last updated on 13.07.2024
Most recent event   Tooltip08.07.2016Lapse of the patent in a contracting state
New state(s): HU		published on 10.08.2016  [2016/32]
Applicant(s)For all designated states
Pathogen Removal and Diagnostic Technologies, Inc.
1 Rodney Square
Wilmington, DE 19801 / US
For all designated states
NORTH CAROLINA STATE UNIVERSITY
2401 Research Drive, Suite 1122, Campus Box 8210
Raleigh, NC 27695-8210 / US
[2008/32]
Inventor(s)01 / Hammond, David
4916m Ripplemead Court
Laytonsville, MD 20882 / US
02 / Lathrop, Julia T.
1000 Poplar Drive
Falls Church, VA 22046 / US
03 / Cervenakova, Larisa
15 Welwyn Way
Rockville, MD 20850 / US
04 / Carbonell, Ruben G.
6105 Godfrey Drive
Raleigh, NC 27612 / US
 [2008/32]
Representative(s)Adamson Jones
Park View House
58 The Ropewalk
Nottingham NG1 5DW / GB
[N/P]
Former [2014/08]Adamson Jones
BioCity Nottingham Pennyfoot Street Nottingham
Nottinghamshire NG1 1GF / GB
Former [2009/27]Adamson Jones
BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF / GB
Former [2008/34]Hutter, Anton, et al
AdamsonJones BioCity Nottingham Pennyfoot Street Nottingham
NG1 1GF / GB
Former [2008/32]Hutter, Anton, et al
Adamson Jones BioCity Nottingham Pennyfoot Street Nottingham
Nottinghamshire NG1 1GF / GB
Application number, filing date08150151.203.12.2003
[2008/32]
Priority number, dateUS20020430423P03.12.2002         Original published format: US 430423 P
[2008/32]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1953551
Date:06.08.2008
Language:EN
[2008/32]
Type: A3 Search report 
No.:EP1953551
Date:18.03.2009
[2009/12]
Type: B1 Patent specification 
No.:EP1953551
Date:19.02.2014
Language:EN
[2014/08]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.2009
ClassificationIPC:C07K5/083, C07K5/087, C07K5/093, C07K5/097, C07K14/47, G01N33/68
[2013/24]
CPC:
G01N33/6896 (EP,US); A61P25/00 (EP); C07K14/47 (EP,US);
C07K5/0808 (EP,US); C07K5/081 (EP,US); C07K5/0812 (EP,US);
C07K5/0819 (EP,US); C07K5/0821 (EP,US); G01N2800/2828 (EP,US) (-)
Former IPC [2012/13]G01N33/53, G01N33/543, G01N33/567, C07K16/00, A61K39/395, G01N33/68
Former IPC [2008/32]G01N33/53, G01N33/543, G01N33/567, C07K16/00, A61K39/395
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2008/32]
TitleGerman:Prionen-Protein-Liganden und Verfahren zu deren Verwendung[2008/32]
English:Prion protein ligands and methods of use[2008/32]
French:Ligands de protéine de prion et procédés d'utilisation[2008/32]
Examination procedure15.09.2009Examination requested  [2009/43]
09.10.2009Despatch of a communication from the examining division (Time limit: M04)
15.01.2010Reply to a communication from the examining division
10.11.2010Despatch of a communication from the examining division (Time limit: M04)
15.03.2011Reply to a communication from the examining division
02.05.2012Communication of intention to grant the patent
04.09.2012Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.09.2012Fee for grant paid
31.10.2012Despatch of a communication from the examining division (Time limit: M06)
08.04.2013Reply to a communication from the examining division
27.05.2013Communication of intention to grant the patent
01.10.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP03808431.5  / EP1573323
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030808431) is  17.07.2007
Opposition(s)20.11.2014No opposition filed within time limit [2015/05]
Fees paidRenewal fee
10.01.2008Renewal fee patent year 03
10.01.2008Renewal fee patent year 04
10.01.2008Renewal fee patent year 05
19.12.2008Renewal fee patent year 06
23.10.2009Renewal fee patent year 07
24.12.2010Renewal fee patent year 08
27.12.2011Renewal fee patent year 09
24.04.2013Renewal fee patent year 10
25.12.2013Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.12.201210   M06   Fee paid on   24.04.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.12.2003
BG19.02.2014
CY19.02.2014
CZ19.02.2014
EE19.02.2014
MC19.02.2014
RO19.02.2014
SI19.02.2014
SK19.02.2014
[2016/32]
Former [2016/27]BG19.02.2014
CY19.02.2014
CZ19.02.2014
EE19.02.2014
MC19.02.2014
RO19.02.2014
SI19.02.2014
SK19.02.2014
Former [2016/25]BG19.02.2014
CY19.02.2014
CZ19.02.2014
EE19.02.2014
RO19.02.2014
SI19.02.2014
SK19.02.2014
Former [2015/24]CY19.02.2014
CZ19.02.2014
EE19.02.2014
RO19.02.2014
SI19.02.2014
SK19.02.2014
Former [2014/50]CY19.02.2014
CZ19.02.2014
EE19.02.2014
RO19.02.2014
SK19.02.2014
Former [2014/49]CY19.02.2014
CZ19.02.2014
EE19.02.2014
RO19.02.2014
Former [2014/48]CY19.02.2014
CZ19.02.2014
EE19.02.2014
Former [2014/37]CY19.02.2014
Documents cited:Search[DA]WO0177687  (VI TECHNOLOGIES INC [US], et al) [DA] 1-14 * page 8, line 25 - line 30 * * page 14, line 20 - page 16, line 18 ** claims 27-29,40,41,45-47 *;
 [X]WO0181367  (UNIV GENEVE [CH], et al) [X] 1-3,13,14 * example 4 *;
 [X]  - KOBAYASHI I ET AL, "RELATIVE RATES OF MONO IODO TYROSINE AND DI IODO TYROSINE LIBERATION DURING ENZYMATIC HYDROLYSIS OF IODINATED DI PEPTIDES AND TRI PEPTIDES", ENDOCRINOLOGY, (1973), vol. 92, no. 6, ISSN 0013-7227, pages 1612 - 1616, XP009111373 [X] 1-3,13,14 * page 1612, column L, paragraph 2 - column R, paragraph 3 *
by applicantUS5750361
 US5808011
 US5834318
 WO0177687
    - INGROSSO, L. ET AL., "Congo red prolongs the incubation period in scrapie-infected hamsters", J. VIROLOGY, (1995), vol. 69, pages 506 - 508
    - TAGLIAVINI, F. ET AL., "Effectiveness of anthracycline against experimental prion diseases in Syrian hamsters", SCIENCE, (1997), vol. 276, doi:doi:10.1126/science.276.5315.1119, pages 1119 - 1122, XP002043060

DOI:   http://dx.doi.org/10.1126/science.276.5315.1119
    - PRIOLA, S.A. ET AL., "Porphyrin and Phthalocyanine antiscrapie compounds", SCIENCE, (2000), vol. 287, pages 1503 - 1506
    - STOCKEL ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 7185 - 7193
    - SOTO, C. ET AL., "Reversion of prion protein conformational changes in synthetic -sheet breaker peptides", LANCET, (2000), vol. 355, doi:doi:10.1016/S0140-6736(99)11419-3, pages 192 - 197, XP004813317

DOI:   http://dx.doi.org/10.1016/S0140-6736(99)11419-3
    - CAUGHEY, B. ET AL., "Binding of the Protease-sensitive form of prion protein PrP to Sulphated Glycosaminoglycan and Congo Red", J. VIROLOGY, (1994), vol. 68, pages 2135 - 2141, XP002056076
    - KASCSAK, R.J. ET AL., "Immunodiagnosis of prion disease", IMMUNOLOGICAL INVEST., (1997), vol. 26, doi:doi:10.3109/08820139709048931, pages 259 - 268, XP002916122

DOI:   http://dx.doi.org/10.3109/08820139709048931
    - FISCHER, M.B. ET AL., "Binding of disease-associated prion protein to plasminogen", NATURE, (2000), vol. 408, doi:doi:10.1038/35044100, pages 479 - 483, XP002520611

DOI:   http://dx.doi.org/10.1038/35044100
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, page 482
    - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 443
    - PEARSON; LIPMAN, PROC. NATL. ACAD. SCI., (1988), vol. 85, page 2444
    - MERRIFIELD, SCIENCE, (1986), vol. 232, pages 241 - 247
    - JAMESON ET AL., NATURE, (1994), vol. 368, pages 744 - 746
    - SAMSON ET AL., ENDOCRINOLOGY, (1996), vol. 137, pages 5182 - 5185
    - DEGRADO, ADV. PROTEIN CHEM., (1988), vol. 39, pages 51 - 124
    - ROSE ET AL., ADV. PROTEIN CHEM., (1985), vol. 37, pages 1 - 109
    - AUBRY ET AL., INT. J. PEPT. PROTEIN RES., (1981), vol. 18, pages 195 - 202
    - SAFIR, J. ET AL., "Eight Prion Strains Have PrPsc Molecules With Different Conformations", NATURE MEDICINE, (1998), vol. 4, pages 1157 - 1165
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.